Fresenius Kabi: all 90 studies

Page 1 of 1. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.

• Glycaemic Index Measurement of an Oral Nutritional Supplement With Biomarker Assessment and Lifestyle Monitoring in Healthy ParticipantsNot yet recruitingNCT07479251Not applicable
• Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] MelanomaRecruitingNCT07221734Phase 3
• Evaluation of Safety and Efficacy of Supportan® DrinkRecruitingNCT06902402Not applicable
• Suitability of a High-energy, Low-protein Formula (Renalive® LP)RecruitingNCT06892249Not applicable
• Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven TreatmentRecruitingNCT06274788
• Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult PatientsRecruitingNCT06049680Phase 4
• To Test the Food for Special Medical Purpose in Perioperative Patients With Gastrointestinal CancerRecruitingNCT05606848Not applicable
• SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory DiseasesRecruitingNCT05598684
• Evaluation of the Aurora Xi New Nomogram Software 2.0CompletedNCT06122935Not applicableResults posted
• A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis.CompletedNCT05338086Phase 3Results posted
• A Study Comparing the Pharmacokinetic Similarity of MB09 and EU/US-Sourced XgevaCompletedNCT05299073Phase 1Results posted
• A PK Study Comparing MB05, EU-sourced Synagis® and US-sourced Synagis® in Healthy Volunteers.CompletedNCT05121246Phase 1Results posted
• A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With OsteoporosisCompletedNCT04934072Phase 3Results posted
• Exploratory Study to Estimate the Prophylactic Efficacy of Palivizumab in Healthy Adult Participants Inoculated With RSVCompletedNCT04540627Phase 1Results posted
• MSB11456 in Participants With Moderately to Severely Active Rheumatoid ArthritisCompletedNCT04512001Phase 3Results posted
• A Study Comparing the Pharmacokinetic Similarity of MB02-SP, MB02-DM and US Licensed-Avastin®.CompletedNCT04408989Phase 1Results posted
• Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male VolunteersCompletedNCT04238663Phase 1Results posted
• A Pharmacokinetic Study Comparing MB02 And EU Avastin® In Healthy Male VolunteersCompletedNCT04238650Phase 1Results posted
• Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of AgeTerminatedNCT03563222Phase 4Results posted
• A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)CompletedNCT03296163Phase 3Results posted
• A Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male VolunteersCompletedNCT03293654Phase 1Results posted
• Three-Chamber Bags Retrospective Study in SpainCompletedNCT03284398Results posted
• MSB11022 in Moderate to Severe Rheumatoid ArthritisCompletedNCT03052322Phase 3Results posted
• MSB11022 in Moderate to Severe Chronic Plaque PsoriasisCompletedNCT02660580Phase 3Results posted
• Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and InfantsTerminatedNCT02579265Phase 3Results posted
• Evaluation of the AMICUS RBCx System in Sickle Cell PatientsCompletedNCT02372877Not applicableResults posted
• Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's LymphomaCompletedNCT02268045Phase 3Results posted
• Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC PatientsCompletedNCT02069704Phase 1Results posted
• Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS DeviceCompletedNCT01210716Phase 3Results posted
• Voluven® in Paediatric PatientsCompletedNCT00860405Phase 4Results posted
• Effects of Voluven on Hemodynamics and Tolerability of Enteral Nutrition in Patients With Severe SepsisCompletedNCT00464204Phase 3Results posted
• A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)Active, not recruitingNCT06687369Phase 3
• A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [Proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid ArthritisCompletedNCT06596772Phase 3
• A Study Investigating the Safety, Absorption, and Elimination of MB04, a New Compound That May Potentially be Used in the Treatment of Autoimmune DisordersCompletedNCT06392074Phase 1
• Real World Use of Tocilizumab Biosimilar studYActive, not recruitingNCT06247722
• Oral Nutritional Supplementation of Hemodialysis PatientsCompletedNCT05333692Not applicable
• Efficacy and Safety of SmofKabiven Extra Nitrogen for Parenteral Nutrition in Patients Receiving Intensive CareCompletedNCT05257031Phase 3
• bIosimilar of aDalimumab, an European evAluationStatus unknownNCT05190484
• A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic ResponseCompletedNCT05051943
• Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)WithdrawnNCT04807478
• Observational Cohort Study on the Use of Parenteral Nutrition and Clinical Outcomes in Adult Critically Ill PatientsCompletedNCT04143503
• Comparison of PK and Tolerability of MSB11022 Administered by AI or PFSCompletedNCT04018599Phase 1
• Reaching Protein Target With SmofKabiven® Extra Nitrogen vs Olimel N9E During the Early Phase of Acute Critical IllnessTerminatedNCT03992716Phase 4
• Efficacy & Safety of SmofKabiven Emulsion for Infusion vs Hospital Compounded "All in One" for Parenteral NutritionCompletedNCT03792100Phase 3
• Efficacy and Safety of SmofKabiven Peripheral Versus Compounded EmulsionCompletedNCT03792087Phase 3
• Blood Glucose Response After Oral Intake of Lactulose in Mildly Constipated Patients With Diabetes Mellitus Type 2CompletedNCT03666546Phase 4
• Chronic Kidney Disease Observational Database - TaiwanCompletedNCT03619564
• Nutrition Insights Day AsiaCompletedNCT03606603
• Study to Assess Safety and Efficacy of Kabiven® in Pediatric Patients 2 to 16 Years of AgeWithdrawnNCT03481894Phase 4
• Quality of Care of Oncological Patients With HPNTerminatedNCT03425435
• Efficacy Study of Long-term Parenteral Nutrition With SmofKabiven® E in Lung Cancer Patients Under Anticancer TherapyTerminatedNCT03355079Phase 4
• Safety and Efficacy of a 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Trauma PatientsCompletedNCT03338218Phase 4
• Pharmacokinetics/Pharmacodynamics (PK/PD) Equivalence Study of MSB11456CompletedNCT03282851Phase 1
• Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal SurgeryCompletedNCT03278548Phase 4
• Safety and Immunogenicity of MSB11455 in Healthy ParticipantsCompletedNCT03251339Phase 1
• Pharmacokinetic/Pharmacodynamic Equivalence of MSB11455 in Healthy SubjectsCompletedNCT03251248Phase 1
• Short-term Metabolic Effects of Ketosteril® Supplemented Low Protein Diet in Pre-dialysis Chronic Kidney Disease (CKD) PatientsCompletedNCT03077048Phase 1/2
• MSB11022 in Healthy SubjectsCompletedNCT03014947Phase 1
• Blood Glucose Response After Oral Intake of Lactulose in Healthy VolunteersCompletedNCT02968498Not applicable
• Tolerance and Compliance of a High Caloric, High Protein Oral Nutritional Supplement - Scheduled IntakeCompletedNCT02938247Not applicable
• Tolerance and Compliance of a High Caloric, High Protein Oral Nutritional Supplement - Free IntakeCompletedNCT02938234Not applicable
• Bioequivalence Study of Fulvestrant Injection 50 mg/mL in Healthy Post-menopausal Female SubjectsCompletedNCT02795039Phase 1
• Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)CompletedNCT02756520
• Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-027-CNI)CompletedNCT02746133
• Observational Study on Chronic Kidney Disease Treatment With a Ketosteril Supplemented Protein-restricted DietCompletedNCT02649205
• Screening Day Latin AmericaCompletedNCT02583880
• Efficacy and Safety Study of a Low-carbohydrate Tube Feed in Critically Ill Patients Under Insulin TherapyTerminatedNCT02503527Not applicable
• Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)CompletedNCT02086227Phase 1
• Therapeutic Equivalence (TE) Study of Propofol 2% MCT Fresenius (MCT=Medium-Chain Triglycerides) Compared With Diprivan® in Patients Undergoing Elective SurgeryCompletedNCT01856998Phase 3
• Fluid Resuscitation in Patients Suffering From Burns InjuryTerminatedNCT01689506Phase 4
• VolulyteTM in Cardiac SurgeryCompletedNCT01553617Phase 4
• Safety, Acceptability and Efficacy of a Long-term Intervention With a Diabetes-specific Low-carbohydrate, High-mono-unsaturated Fatty Acid Containing Oral Nutritional Supplement on Glycaemic Control in Type 2 Diabetic PatientsCompletedNCT01241695Not applicable
• Study to Obtain Volume Effect and Safety Data on 6 % Hydroxyethyl Starch 130/0.4 in Pediatric and Adult Patients Undergoing Major Elective SurgeryCompletedNCT01127477Phase 3
• The Effect of a New Specific Enteral Formula Compared to a Standard Formula on the Tolerability of a Combined Radio- and Chemotherapy in Cancer PatientsCompletedNCT01025167Not applicable
• Trial of 6% HES130/0.4CompletedNCT01010022Phase 3
• A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast CancerStatus unknownNCT00915369Phase 1
• Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Chronic Heart Failure and Chronic Obstructive Pulmonary Disease PatientsCompletedNCT00852020Not applicable
• Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer PatientsTerminatedNCT00851448Not applicable
• Effectiveness and Tolerability of an Oral Nutritional Supplement (PreOP Booster) Given Before SurgeryCompletedNCT00730808Not applicable
• Efficacy of Voluven® for the Prevention of Hypotension During Spinal Anesthesia for Cesarean SectionCompletedNCT00694343Phase 4
• Study on Safety, Tolerance and Metabolic Effects of a Nutritional Supplement, Given as a Drink Before Gallbladder SurgeryCompletedNCT00662376Not applicable
• Gastric Emptying Study After Administration of a High Caloric Sip FeedCompletedNCT00600678Not applicable
• Preoperative Oral Nutritional Supplement (preOP Booster) in Visceral SurgeryCompletedNCT00503334Not applicable
• Intradialytic Parenteral Nutrition in Hemodialysis PatientsCompletedNCT00501956Phase 4
• Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral NutritionCompletedNCT00451646Phase 3
• Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN)CompletedNCT00363987Phase 4
• Study to Evaluate the Effect of Hydroxyethyl Starch (HES) in Complications of Patients After Abdominal SurgeryCompletedNCT00308126Phase 4
• Hydroxyethyl Starch (130/0.4) for Intravascular Volume Therapy in Liver TransplantationTerminatedNCT00308100Phase 4
• The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer PatientsCompletedNCT00292279Phase 3
• The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative PatientsCompletedNCT00247338Phase 4

← Fresenius Kabi overview and focus areas